archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has completed custom software development work for a US Department of Defense (DoD) project first announced in October 2025, with the solution now “production-ready”.
The only remaining item is a final third-party integration component that depends on input from an external provider, with delivery targeted for the first week of February. Acceptance criteria have been agreed and the timing confirmed by all parties.
Virtuix Holdings Inc (NASDAQ:VTIX), a developer of full-body virtual reality systems, began trading on the Nasdaq Global Market on Tuesday under the ticker symbol VTIX, marking a milestone for the Austin, Texas–based company as it looks to scale its technology across consumer, enterprise and defense markets.
Shares of the company closed at $24.39, up nearly 22% in its first day of trading.
M2i Global Inc (OTC:MTWO), a developer of global supply chains for critical minerals, and Volato Group, Inc. (NYSE American: SOAR), a technology-driven company, said their proposed merger aligns with recent US policy aimed at strengthening domestic and allied supply chains for processed critical minerals.
The White House on January 14 announced measures under Section 232 of the Trade Expansion Act, directing negotiations to adjust imports of processed critical minerals and derivative products, citing national security concerns.
Montero Mining and Exploration Ltd (TSX-V:MON, OTC:MXTRF) reported that Andrew Thomson has stepped down as a director and chair of its audit committee to pursue other professional opportunities.
Thomson, a long-standing board member, was credited with providing guidance and oversight, particularly in corporate governance and strategic matters. The company expressed gratitude for his contributions and wished him success in his future endeavors.
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) said it has mutually terminated a licensing and collaboration agreement with China’s Qilu Pharmaceutical, regaining full rights to its cancer drug candidate certepetide in the Greater China region.
The February 2021 agreement granted Qilu exclusive rights to develop and commercialize certepetide in Mainland China, Hong Kong, Macau and Taiwan.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) has announced the launch of Nextech Credit, a universal, dollar-denominated enterprise credit system designed to be used across its portfolio of AI-powered event and engagement platforms.
The company said the proprietary system allows enterprise clients to purchase credits that can be spent interchangeably across Nextech3D.ai business units, including Eventdex for event registration and ticketing, Map D for spatial navigation, and Krafty Labs for virtual and in-person engagement programs. Nextech Credit is priced on a one-to-one basis with the US dollar.
Roebuck Food Group Plc (LSE:RFG) shares were up 10% in Tuesday morning's trade, thanks to a trading update that highlighted progress at GlasPort Bio and performance in its plant-based ingredients division.
Galway-based GlasPort Bio, which works on agricultural innovations that focus on sustainability, is said to have made “significant progress and achieved many milestones towards commercialisation" during the year.
European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has agreed to acquire US-based titanium producer Velta Holding in an all-scrip deal that would broaden the company’s exposure beyond lithium into another strategically important critical material.
Under a binding agreement announced on Tuesday, European Lithium will acquire 100% of Velta for consideration of about 173 million fully paid ordinary shares, subject to final due diligence and the satisfaction of customary conditions precedent. Upon completion, the shares will be issued to Velta’s existing shareholders.
Nova Minerals Ltd (ASX:NVA, NASDAQ:NVA, OTC:NVAAF, FRA:QM3) has highlighted December 2025 quarterly progress led by its securing of US$43.4 million (A$65.5 million) in non-dilutive funding from the US Department of War (DoW), fully funding stage one development of a domestic antimony supply chain at its Estelle Project in Alaska.
The company said the Defense Production Act Title III award materially strengthened Nova’s balance sheet and supports its strategy to become a fully integrated US-based producer of military-grade antimony, with first production targeted for late 2026 to early 2027.